200字范文 > 组织型纤溶酶原激活物／1型纤溶酶原激活物抑制物 Tissue plasminogen activactor/p

组织型纤溶酶原激活物／1型纤溶酶原激活物抑制物 Tissue plasminogen activactor/p

时间：2021-07-26 13:06:01

组织型纤溶酶原激活物/1型纤溶酶原激活物抑制物,Tissue plasminogen activactor/plasminogen activator inhibitor-1

1)Tissue plasminogen activactor/plasminogen activator inhibitor-1组织型纤溶酶原激活物/1型纤溶酶原激活物抑制物

2)t-PA/PAI-1组织型纤溶酶原激活物/纤溶酶原激活抑制物-1

3)PAI-1组织型纤溶酶原激活物抑制物-1

1.Study of relationship between insulin resistance and activity ofPAI-1 in patients with cerebral infarction;脑梗死患者的胰岛素抵抗与血浆组织型纤溶酶原激活物抑制物-1活性相关性的研究

4)plasminogen activator inhibitor-1/tissue plasminogen activator纤溶酶原激活物抑制物-1/组织纤溶酶原激活物

5)Plasminogen activator inhibitor-1组织型纤溶酶原激活剂抑制物-1

6)tissue-type plasminogen activator组织型纤溶酶原激活物

1.Correlation between activity oftissue-type plasminogen activator and extracellular matrix in retina of rats during ischemia and reperfusion;缺血再灌注大鼠视网膜组织型纤溶酶原激活物活性与细胞外基质的相关性

2.Clinical significance and concentration changes of plasmatissue-type plasminogen activator and plasminogen activator inhibitor-1 antigen in patients with chronic heart failure;慢性心力衰竭患者血浆组织型纤溶酶原激活物和纤溶酶原激活物抑制物-1含量变化及其临床意义

3.DNA family shuffling oftissue-type plasminogen activator genes;组织型纤溶酶原激活物基因的DNA改组

英文短句/例句

1.Preliminary Study on DNA Family Shuffling of Tissue-type Plasminogen Activator Genes;组织型纤溶酶原激活物DNA改组的探索研究

2.Intravenous thrombolytic therapy with recombinant-tissue plasminogen activator for super early stage of cerebral infarction重组组织型纤溶酶原激活物rt-PA静脉溶栓治疗超早期脑梗死

3.Relationship between the Changes of Activity of Tissue-Type Plasminogen Activator on Brains and Cerebral Edema in Asphyxia Status of Mice窒息鼠脑组织型纤溶酶原激活物活性变化与脑水肿的关系

4.Activity of plasma tissue plasminogen activator and plasminogen activator inhibitor in patients with hypertensive disorder complicating pregnancy妊娠期高血压疾病患者血浆组织型纤溶酶原激活物及其抑制物的活性变化

5.Inhibitory Effect on LPS-induced Retinal Microglial Activation of Downregulation of t-PA Expression by siRNA InterferenceRNA干扰敲减视网膜小胶质细胞中组织型纤溶酶原激活物的表达对其活化反应的影响

6.Influence of Tissue Plasminogen Activator and Its Inhibitors on Neurodegeneration of Spinal Cord after Sciatic Nerve Transection;坐骨神经离断后组织型纤溶酶原激活物及其抑制物对脊髓神经元退变的影响

7.Expressions of Survivin and uPA in human cerebral gliomas脑胶质瘤组织中Survivin和尿激酶型纤溶酶原激活物蛋白的表达

parison of Recombinant Tissue Plasminogen Activator, Urokinase and Defibrase in Vitro Simulation of Thrombolytic Test重组织型纤溶酶原激活剂、尿激酶和降纤酶体外溶栓效果比较

9.Clinical Study of the Expression of Tissue Factor and Urokinase Plasminogen Activator Receptor in Breast Cancer组织因子、尿激酶型纤溶酶原激活剂受体在乳腺癌中的表达

10.Evaluation of the therapeutic effect of thrombolytic therapy with rt-PA and nursing intervention in patients with acute myocardial infarction急性心肌梗死重组组织型纤溶酶原激活剂溶栓治疗的观察及护理

11.Therapeutic effect observation of thrombolysis with rt-PA intravenous in recurrent cerebral infarction重组组织型纤溶酶原激活剂对再发性脑梗死静脉溶栓治疗评价

12.Therapeutic Effect of Ultra Earlier Thrombolysis of Recombinant Tissue Plasminogen Activator in Acute Cerebral Infarction重组组织型纤溶酶原激活剂超早期溶栓治疗急性脑梗死的疗效

13.Thrombolytic therapy with intravenous recombinant tissue plasminogen activator for acute cerebral infarction重组组织型纤溶酶原激活剂静脉溶栓治疗急性脑梗死19例

14.The Effect of Astragalus and Safflower Mixture on Expression of Plasminogen Activator Inhibitor 1 in Renal Tubulointerstitial Fibrosis in Rats with Unilateral Ureteral Obstruction;芪红合剂对肾间质纤维化模型大鼠肾组织中纤溶酶原激活物抑制物-1表达的影响

15.Study on Recombinant Nonglycosylated Urokinase-type Plasminogen Activator;重组非糖基化尿激酶型纤溶酶原激活剂的研究

16.The Recombinant Human Tissue-type Plasminogen Activator in the Treatment of Deep Venous Thrombosis of the Lower Extremities重组组织型纤溶酶原激活剂治疗下肢深静脉血栓形成的临床应用

17.Experimental study on prevention of the peritoneal adhesion by recombinant tissue-type plasminogen activator on rats重组组织型纤溶酶原激活剂预防大鼠腹腔粘连的实验研究

18.Therapeutic effect evaluation of recombinant tissue plasminogen activator in hyper acute cerebral infarction重组组织型纤溶酶原激活剂治疗急性脑梗死的疗效评价